Significant medical abnormality (defined as a pre- existing condition AE/condition ≥ Grade 3 according to NCI CTCAE v 4.0 and any condition which, in the opinion of the investigator, would prevent full participation in this trial (including the Long- Term Fo llow-Up), or would interfere with the evaluation of the trial endpoints. 22.